0000000000034745

AUTHOR

Maximilian P Brandt

showing 2 related works from this author

Multicenter analysis of serum tumor markers, treatment patterns, and relapse in patients with testicular cancer in clinical stage IS.

2020

5052 Background: Testicular germ cell tumors (TGCT) in clinical stage I (CSI) are tumors confined to the testis without evidence of metastasis. Around 50% of all TGCT patients present with elevated serum tumor markers (TM) such as alpha-feto protein (AFP), beta-humanochoriongonadotropin (ß-HCG) and lactate-dehydrogenase (LDH). After ablatio testis, TMs usually return to normal according to half-life kinetics, however, in clinical stage IS (CSIS) TMs remain elevated or increase after surgery. Follow-up data on CSIS is scarce and our study aims to assess clinical characteristics and oncologic outcomes in a large TGCT cohort. Methods: In this multicenter study we collected data from 5 tertiar…

OncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.diseaseTesticular germ cellMetastasisOncologyInternal medicineMedicineIn patientStage (cooking)businessTesticular cancerJournal of Clinical Oncology
researchProduct

What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications…

2016

Jens Mani,1 Stefan Vallo,1 Maximilian P Brandt,1 Kilian M Gust,1 Claudia Bartsch,1 Johannes Daechert,1 Igor Tsaur,1 Georg Bartsch,2,* Axel Haferkamp1,* 1Department of Urology, Goethe University Hospital, Frankfurt am Main, 2Department of Urology, Johannes Gutenberg University Hospital Mainz, Mainz, Germany *These authors contributed equally to this work Purpose: This study compares early complications after cystectomy and urinary diversion (UD) stratified by the surgical focus and case load of two different department chairpersons in a single institution in two time periods. Creating clear data about complications that can affect the quality of life is an important tool for patient…

medicine.medical_specialtyClavien-Dindo Classificationbusiness.industryHealth Policymedicine.medical_treatmentSignificant differenceUrinary diversion030232 urology & nephrologyMedicine (miscellaneous)University hospitalSurgeryCystectomy03 medical and health sciences0302 clinical medicineVolume settingQuality of lifePatient Preference and Adherence030220 oncology & carcinogenesisMedicinebusinessComplicationPharmacology Toxicology and Pharmaceutics (miscellaneous)Social Sciences (miscellaneous)Patient Preference and Adherence
researchProduct